Su WC - Search Results

1

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer.

Jänne PA, Baik C, Su WC, Johnson ML, Hayashi H, Nishio M, Kim DW, Koczywas M, Gold KA, Steuer CE, Murakami H, Yang JC, Kim SW, Vigliotti M, Shi R, Qi Z, Qiu Y, Zhao L, Sternberg D, Yu C, Yu HA. Jänne PA, et al. Among authors: su wc. Cancer Discov. 2022 Jan;12(1):74-89. doi: 10.1158/2159-8290.CD-21-0715. Epub 2021 Sep 21. Cancer Discov. 2022. PMID: 34548309 Free PMC article. Clinical Trial.

2

Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer.

Lai WW, Chen FF, Wu MH, Chow NH, Su WC, Ma MC, Su PF, Chen H, Lin MY, Tseng YL. Lai WW, et al. Among authors: su wc, su pf. Ann Thorac Surg. 2001 Dec;72(6):1868-76. doi: 10.1016/s0003-4975(01)03207-6. Ann Thorac Surg. 2001. PMID: 11789762

3

An open, multi-centre, phase II clinical trial to evaluate the efficacy and safety of paclitaxel, UFT, and leucovorin in patients with advanced gastric cancer.

Chao Y, Li CP, Chao TY, Su WC, Hsieh RK, Wu MF, Yeh KH, Kao WY, Chen LT, Cheng AL. Chao Y, et al. Among authors: su wc. Br J Cancer. 2006 Jul 17;95(2):159-63. doi: 10.1038/sj.bjc.6603225. Epub 2006 Jun 27. Br J Cancer. 2006. PMID: 16804524 Free PMC article. Clinical Trial.

4

Hormone replacement therapy and lung cancer risk in Chinese.

Chen KY, Hsiao CF, Chang GC, Tsai YH, Su WC, Perng RP, Huang MS, Hsiung CA, Chen CJ, Yang PC; GEFLAC Study Group. Chen KY, et al. Among authors: su wc. Cancer. 2007 Oct 15;110(8):1768-75. doi: 10.1002/cncr.22987. Cancer. 2007. PMID: 17879370 Free article.

5

Angiogenetic biomarkers in non-small cell lung cancer with malignant pleural effusion: correlations with patient survival and pleural effusion control.

Hsu IL, Su WC, Yan JJ, Chang JM, Lai WW. Hsu IL, et al. Among authors: su wc. Lung Cancer. 2009 Sep;65(3):371-6. doi: 10.1016/j.lungcan.2008.12.007. Epub 2009 Jan 21. Lung Cancer. 2009. PMID: 19157636

6

Modified, weekly dosing with docetaxel and cisplatin as first-line therapy in advanced non-small cell lung cancer.

Hsiao SC, Su WC. Hsiao SC, et al. Among authors: su wc. Natl Med J India. 2009 Mar-Apr;22(2):67-9. Natl Med J India. 2009. PMID: 19852339

7

Triweekly reduced-dose docetaxel combined with cisplatin in recurrent/metastatic head and neck squamous cell carcinoma: a multicenter phase II study.

Chang PM, Tzeng CH, Chen MH, Tsao CJ, Su WC, Hwang WS, Chang YF, Chang SY, Yang MH. Chang PM, et al. Among authors: su wc. Cancer Chemother Pharmacol. 2011 Dec;68(6):1477-84. doi: 10.1007/s00280-011-1645-5. Epub 2011 Apr 12. Cancer Chemother Pharmacol. 2011. PMID: 21484308 Clinical Trial.

8

Predictive and prognostic value of human copper transporter 1 (hCtr1) in patients with stage III non-small-cell lung cancer receiving first-line platinum-based doublet chemotherapy.

Chen HH, Yan JJ, Chen WC, Kuo MT, Lai YH, Lai WW, Liu HS, Su WC. Chen HH, et al. Among authors: su wc. Lung Cancer. 2012 Feb;75(2):228-34. doi: 10.1016/j.lungcan.2011.06.011. Epub 2011 Jul 23. Lung Cancer. 2012. PMID: 21788094 Free PMC article.

9

Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial.

Yang JC, Shih JY, Su WC, Hsia TC, Tsai CM, Ou SH, Yu CJ, Chang GC, Ho CL, Sequist LV, Dudek AZ, Shahidi M, Cong XJ, Lorence RM, Yang PC, Miller VA. Yang JC, et al. Among authors: su wc. Lancet Oncol. 2012 May;13(5):539-48. doi: 10.1016/S1470-2045(12)70086-4. Epub 2012 Mar 26. Lancet Oncol. 2012. PMID: 22452895 Clinical Trial.

10

Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial.

Miller VA, Hirsh V, Cadranel J, Chen YM, Park K, Kim SW, Zhou C, Su WC, Wang M, Sun Y, Heo DS, Crino L, Tan EH, Chao TY, Shahidi M, Cong XJ, Lorence RM, Yang JC. Miller VA, et al. Among authors: su wc. Lancet Oncol. 2012 May;13(5):528-38. doi: 10.1016/S1470-2045(12)70087-6. Epub 2012 Mar 26. Lancet Oncol. 2012. PMID: 22452896 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

602 results

Search Page